Page last updated: 2024-10-29

avapro and Pheochromocytoma, Extra-Adrenal

avapro has been researched along with Pheochromocytoma, Extra-Adrenal in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"Two patients with pheochromocytoma are described in whom treatment with a high dose of an angiotensin receptor blocker was associated with cessation of tumor growth as assessed by serial CT scanning and plasma norepinephrine estimation."1.33AT2 receptor stimulation may halt progression of pheochromocytoma. ( Appleton, DS; Ashby, MJ; Balan, KK; Brown, MJ; Mackenzie, IS, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, MJ1
Mackenzie, IS1
Ashby, MJ1
Balan, KK1
Appleton, DS1

Other Studies

1 other study available for avapro and Pheochromocytoma, Extra-Adrenal

ArticleYear
AT2 receptor stimulation may halt progression of pheochromocytoma.
    Annals of the New York Academy of Sciences, 2006, Volume: 1073

    Topics: Adrenal Gland Neoplasms; Adult; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Disease

2006